Sarepta Therapeutics Stock Analysis

Sarepta Stock Analysis Notes

About 92.0% of the company shares are owned by institutional investors. The company had not issued any dividends in recent years. Sarepta Therapeutics had 1:6 split on the 12th of July 2012. Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts. Sarepta Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 840 people. To find out more about Sarepta Therapeutics contact Douglas Esq at 617 274 4000 or learn more at https://www.sarepta.com.

Sarepta Therapeutics Investment Alerts

Sarepta Therapeutics Upcoming and Recent Events

Sarepta Largest EPS Surprises

View All Earnings Estimates

Sarepta Therapeutics Environmental, Social, and Governance (ESG) Scores

Sarepta Stock Institutional Investors

Note, although Sarepta Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Sarepta Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 11.03 B.

Sarepta Profitablity

The company has Profit Margin (PM) of 0.07 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.05 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.05.

Management Efficiency

Sarepta Therapeutics has return on total asset (ROA) of 0.0151 % which means that it generated a profit of $0.0151 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1227 %, meaning that it created $0.1227 on every $100 dollars invested by stockholders. Sarepta Therapeutics' management efficiency ratios could be used to measure how well Sarepta Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.16 in 2025. Return On Capital Employed is likely to drop to -0.12 in 2025. At this time, Sarepta Therapeutics' Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 3.9 B in 2025, whereas Non Current Liabilities Other is likely to drop slightly above 44.9 M in 2025.

Technical Drivers

As of the 30th of January, Sarepta Therapeutics has the Risk Adjusted Performance of (0.04), coefficient of variation of (1,951), and Variance of 7.64. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sarepta Therapeutics, as well as the relationship between them.

Sarepta Therapeutics Price Movement Analysis

Sarepta Therapeutics Insider Trading Activities

Sarepta Therapeutics Outstanding Bonds

Sarepta Therapeutics Predictive Daily Indicators

Sarepta Therapeutics Corporate Filings

Sarepta Therapeutics Forecast Models

Sarepta Therapeutics' time-series forecasting models are one of many Sarepta Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Sarepta Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Sarepta Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Sarepta shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Sarepta Therapeutics. By using and applying Sarepta Stock analysis, traders can create a robust methodology for identifying Sarepta entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Sarepta analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Sarepta analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Sarepta Therapeutics stock analysis indicators help investors evaluate how Sarepta Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Sarepta Therapeutics shares will generate the highest return on investment. By understating and applying Sarepta Therapeutics stock analysis, traders can identify Sarepta Therapeutics position entry and exit signals to maximize returns.

When running Sarepta Therapeutics' price analysis, check to measure Sarepta Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sarepta Therapeutics is operating at the current time. Most of Sarepta Therapeutics' value examination focuses on studying past and present price action to predict the probability of Sarepta Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sarepta Therapeutics' price. Additionally, you may evaluate how the addition of Sarepta Therapeutics to your portfolios can decrease your overall portfolio volatility.